Kiora Pharmaceuticals Ownership 2024 | Who Owns Kiora Pharmaceuticals Now?

Overview Forecast RevenueFinancials Chart

Institutional Ownership

1.12%

Insider Ownership

2.31%

Retail Ownership

96.57%

Institutional Holders

10.00

Kiora Pharmaceuticals Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ACADIAN ASSET MANAGEMENT LLC	2.93%	0.00%	21,460	21,460	100.00%	70,000	Mar 31, 2023
BLACKROCK INC.	1.97%	-	14,462	-	-	48,303,000	Mar 31, 2023
CITADEL ADVISORS LLC	1.93%	-	14,134	14,134	100.00%	47,208,000	Mar 31, 2023
DIMENSIONAL FUND ADVISORS LP	1.67%	-	12,254	12,254	100.00%	40,928,000	Mar 31, 2023
VANGUARD GROUP INC	1.43%	-	10,503	10,503	100.00%	35,080,000	Mar 31, 2023
NEWEDGE ADVISORS, LLC	0.03%	-	200	200	100.00%	668,000	Mar 31, 2023
UBS GROUP AG	0.02%	-	166	-4,088	-96.10%	555,000	Mar 31, 2023
US BANCORP \DE\	0.01%	-	67	-	-	224,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	0.00%	-	36	36	100.00%	120,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	11	4	57.14%	37,000	Mar 31, 2023
MORGAN STANLEY	0.00%	-	8	-108	-93.10%	27,000	Mar 31, 2023
ALBION FINANCIAL GROUP /UT	0.00%	-	6	-	-	21,000	Mar 31, 2023
BOOTHBAY FUND MANAGEMENT, LLC	-	-	-	-11,679	-100.00%	-	Mar 31, 2023
WALLEYE CAPITAL LLC	-	-	-	-83,300	-100.00%	-	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-4,276	-100.00%	-	Mar 31, 2023
WARBERG ASSET MANAGEMENT LLC	-	-	-	-33,000	-100.00%	-	Mar 31, 2023

Kiora Pharmaceuticals's largest institutional shareholder is ACADIAN ASSET MANAGEMENT LLC, holding 2.93% of the company's total share outstanding, currently valued at $70.00K. The top 10 institutional shareholders own together 10.01% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ACADIAN ASSET MANAGEMENT LLC	2.93%	0.00%	21,460	21,460	100.00%	70,000	Mar 31, 2023
DIMENSIONAL FUND ADVISORS LP	1.67%	-	12,254	12,254	100.00%	40,928,000	Mar 31, 2023
CITADEL ADVISORS LLC	1.93%	-	14,134	14,134	100.00%	47,208,000	Mar 31, 2023
NEWEDGE ADVISORS, LLC	0.03%	-	200	200	100.00%	668,000	Mar 31, 2023
ALBION FINANCIAL GROUP /UT	0.00%	-	6	-	-	21,000	Mar 31, 2023
BLACKROCK INC.	1.97%	-	14,462	-	-	48,303,000	Mar 31, 2023
VANGUARD GROUP INC	1.43%	-	10,503	10,503	100.00%	35,080,000	Mar 31, 2023
US BANCORP \DE\	0.01%	-	67	-	-	224,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	0.00%	-	36	36	100.00%	120,000	Mar 31, 2023
UBS GROUP AG	0.02%	-	166	-4,088	-96.10%	555,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	11	4	57.14%	37,000	Mar 31, 2023
MORGAN STANLEY	0.00%	-	8	-108	-93.10%	27,000	Mar 31, 2023
WARBERG ASSET MANAGEMENT LLC	-	-	-	-33,000	-100.00%	-	Mar 31, 2023
WALLEYE CAPITAL LLC	-	-	-	-83,300	-100.00%	-	Mar 31, 2023
BOOTHBAY FUND MANAGEMENT, LLC	-	-	-	-11,679	-100.00%	-	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-4,276	-100.00%	-	Mar 31, 2023

The largest Kiora Pharmaceuticals shareholder by % of total assets is ACADIAN ASSET MANAGEMENT LLC. The company owns 21.46K shares of Kiora Pharmaceuticals (KPRX), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ACADIAN ASSET MANAGEMENT LLC	2.93%	0.00%	21,460	21,460	100.00%	70,000	Mar 31, 2023
CITADEL ADVISORS LLC	1.93%	-	14,134	14,134	100.00%	47,208,000	Mar 31, 2023
DIMENSIONAL FUND ADVISORS LP	1.67%	-	12,254	12,254	100.00%	40,928,000	Mar 31, 2023
VANGUARD GROUP INC	1.43%	-	10,503	10,503	100.00%	35,080,000	Mar 31, 2023
NEWEDGE ADVISORS, LLC	0.03%	-	200	200	100.00%	668,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	0.00%	-	36	36	100.00%	120,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	11	4	57.14%	37,000	Mar 31, 2023
US BANCORP \DE\	0.01%	-	67	-	-	224,000	Mar 31, 2023
BLACKROCK INC.	1.97%	-	14,462	-	-	48,303,000	Mar 31, 2023
ALBION FINANCIAL GROUP /UT	0.00%	-	6	-	-	21,000	Mar 31, 2023
MORGAN STANLEY	0.00%	-	8	-108	-93.10%	27,000	Mar 31, 2023
UBS GROUP AG	0.02%	-	166	-4,088	-96.10%	555,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-4,276	-100.00%	-	Mar 31, 2023
BOOTHBAY FUND MANAGEMENT, LLC	-	-	-	-11,679	-100.00%	-	Mar 31, 2023
WARBERG ASSET MANAGEMENT LLC	-	-	-	-33,000	-100.00%	-	Mar 31, 2023
WALLEYE CAPITAL LLC	-	-	-	-83,300	-100.00%	-	Mar 31, 2023

As of Mar 31 2023, Kiora Pharmaceuticals's largest institutional buyer is ACADIAN ASSET MANAGEMENT LLC. The company purchased 21.46K stocks of KPRX, valued at $70.00K.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
WALLEYE CAPITAL LLC	-	-	-	-83,300	-100.00%	-	Mar 31, 2023
WARBERG ASSET MANAGEMENT LLC	-	-	-	-33,000	-100.00%	-	Mar 31, 2023
BOOTHBAY FUND MANAGEMENT, LLC	-	-	-	-11,679	-100.00%	-	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-4,276	-100.00%	-	Mar 31, 2023
UBS GROUP AG	0.02%	-	166	-4,088	-96.10%	555,000	Mar 31, 2023
MORGAN STANLEY	0.00%	-	8	-108	-93.10%	27,000	Mar 31, 2023
ALBION FINANCIAL GROUP /UT	0.00%	-	6	-	-	21,000	Mar 31, 2023
BLACKROCK INC.	1.97%	-	14,462	-	-	48,303,000	Mar 31, 2023
US BANCORP \DE\	0.01%	-	67	-	-	224,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	11	4	57.14%	37,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	0.00%	-	36	36	100.00%	120,000	Mar 31, 2023
NEWEDGE ADVISORS, LLC	0.03%	-	200	200	100.00%	668,000	Mar 31, 2023
VANGUARD GROUP INC	1.43%	-	10,503	10,503	100.00%	35,080,000	Mar 31, 2023
DIMENSIONAL FUND ADVISORS LP	1.67%	-	12,254	12,254	100.00%	40,928,000	Mar 31, 2023
CITADEL ADVISORS LLC	1.93%	-	14,134	14,134	100.00%	47,208,000	Mar 31, 2023
ACADIAN ASSET MANAGEMENT LLC	2.93%	0.00%	21,460	21,460	100.00%	70,000	Mar 31, 2023

As of Mar 31 2023, Kiora Pharmaceuticals's biggest institutional seller is WALLEYE CAPITAL LLC. The company sold -83.30K shares of KPRX, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ACADIAN ASSET MANAGEMENT LLC	2.93%	0.00%	21,460	21,460	100.00%	70,000	Mar 31, 2023
CITADEL ADVISORS LLC	1.93%	-	14,134	14,134	100.00%	47,208,000	Mar 31, 2023
DIMENSIONAL FUND ADVISORS LP	1.67%	-	12,254	12,254	100.00%	40,928,000	Mar 31, 2023
VANGUARD GROUP INC	1.43%	-	10,503	10,503	100.00%	35,080,000	Mar 31, 2023
NEWEDGE ADVISORS, LLC	0.03%	-	200	200	100.00%	668,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	0.00%	-	36	36	100.00%	120,000	Mar 31, 2023

Kiora Pharmaceuticals's largest new institutional shareholder by number of shares is ACADIAN ASSET MANAGEMENT LLC, purchased 21.46K shares, valued at $70.00K, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
WALLEYE CAPITAL LLC	-	-	-	-83,300	-100.00%	-	Mar 31, 2023
WARBERG ASSET MANAGEMENT LLC	-	-	-	-33,000	-100.00%	-	Mar 31, 2023
BOOTHBAY FUND MANAGEMENT, LLC	-	-	-	-11,679	-100.00%	-	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-4,276	-100.00%	-	Mar 31, 2023

Kiora Pharmaceuticals's largest sold out institutional shareholder by shares sold is WALLEYE CAPITAL LLC, sold -83.30K shares, valued at -, as of undefined.

Kiora Pharmaceuticals Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
FIDELITY COMMONWEALTH TRUST	0.09%	288,230	-	-	Feb 29, 2024
FIDELITY CONCORD STREET TRUST	0.00%	267,245	-	-	Feb 29, 2024
FIDELITY CONCORD STREET TRUST	0.00%	36,995	-170	-0.46%	Feb 29, 2024
VANGUARD INDEX FUNDS	0.00%	59,968	-	-	Mar 31, 2024
VANGUARD INDEX FUNDS	0.00%	24,566	-24,566	-50.00%	Mar 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC	0.00%	12,254	-	-	Jan 31, 2024
USAA MUTUAL FUNDS TRUST	0.00%	1,657	-	-	Jan 31, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST	0.00%	1,182	-	-	Mar 31, 2024

Kiora Pharmaceuticals's largest mutual fund holder by % of total assets is "FIDELITY COMMONWEALTH TRUST", owning 288.23K shares, compromising 0.09% of its total assets.

Kiora Pharmaceuticals Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Jun, 22	10	-16.67%
31 Mar, 22	12	20.00%
31 Dec, 21	10	-

As of 30 Jun 22, 10 institutions are holding Kiora Pharmaceuticals's shares, representing a decrease of -16.67% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Jun, 22	834,020	0.43%
31 Mar, 22	830,430	3.22%
31 Dec, 21	804,501	-

Kiora Pharmaceuticals (KPRX) has 834.02K shares outstanding as of 30 Jun 22, up 0.43% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Jun, 22	1.12%	90.14%
31 Mar, 22	1.11%	95.64%
31 Dec, 21	1.08%	-

As of 30 Jun 22, Kiora Pharmaceuticals is held by 1.12% institutional shareholders, representing a 90.14% growth compared to 31 Mar 22.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Jun, 22	5	-28.57%
31 Mar, 22	7	-30.00%
31 Dec, 21	10	-

5 institutional shareholders have increased their position in KPRX stock as of 30 Jun 22 compared to 7 in the previous quarter (a -28.57% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Jun, 22	2	-
31 Mar, 22	2	-
31 Dec, 21	-	-

2 institutional shareholders have reduced their position in KPRX stock as of 30 Jun 22 compared to 2 in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Jun, 22	10	-16.67%	834,020	0.43%	1.12%	90.14%	5	-28.57%	2	-
31 Mar, 22	12	20.00%	830,430	3.22%	1.11%	95.64%	7	-30.00%	2	-
31 Dec, 21	10	-	804,501	-	1.08%	-	10	-	-	-

Kiora Pharmaceuticals Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Aug 15, 2024	Tosca Melissa	officer	CFO	P-Purchase	Buy	2,000	$3.21	$6.42K	13,599
Jun 14, 2024	Tosca Melissa	officer	EVP Finance	P-Purchase	Buy	100	$5.25	$525.00	3,979
Jun 14, 2024	Daniels Eric Joseph	officer	Chief Development Officer	P-Purchase	Buy	1,431	$5.29	$7.57K	11,222
Jun 13, 2024	Parsons Erin	director	-	P-Purchase	Buy	5,260	$4.88	$25.67K	5,260
Jun 13, 2024	Strem Brian M.	director, officer	President and CEO	P-Purchase	Buy	3,000	$5.00	$15.00K	14,531

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Aug 15, 2024	Tosca Melissa	officer	CFO	P-Purchase	Buy	2,000	$3.21	$6.42K	13,599
Jun 14, 2024	Tosca Melissa	officer	EVP Finance	P-Purchase	Buy	100	$5.25	$525.00	3,979
Jun 14, 2024	Daniels Eric Joseph	officer	Chief Development Officer	P-Purchase	Buy	1,431	$5.29	$7.57K	11,222
Jun 13, 2024	Parsons Erin	director	-	P-Purchase	Buy	5,260	$4.88	$25.67K	5,260
Jun 13, 2024	Strem Brian M.	director, officer	President and CEO	P-Purchase	Buy	3,000	$5.00	$15.00K	14,531

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Aug 15, 2024	Tosca Melissa	officer	CFO	P-Purchase	Buy	2,000	$3.21	$6.42K	13,599
Jul 03, 2024	Strem Brian M.	director, officer	President and CEO	A-Award	Buy	31,259	$4.35	$135.98K	31,259
Jul 03, 2024	Strem Brian M.	director, officer	President and CEO	A-Award	Buy	15,629	-	-	30,160
Jul 03, 2024	Tosca Melissa	officer	CFO	A-Award	Buy	15,239	$4.35	$66.29K	15,239
Jul 03, 2024	Tosca Melissa	officer	CFO	A-Award	Buy	7,620	-	-	11,599
Jul 03, 2024	Walters-Hoffert Lisa	director			Buy	-	-	-	-
Jul 03, 2024	Daniels Eric Joseph	officer	Chief Development Officer	A-Award	Buy	7,355	-	-	18,577
Jul 03, 2024	Daniels Eric Joseph	officer	Chief Development Officer	A-Award	Buy	14,710	$4.35	$63.99K	14,710
Jul 03, 2024	Stengone Carmine N.	director	-	A-Award	Buy	1,778	$4.35	$7.73K	1,778
Jul 03, 2024	Parsons Erin	director	-	A-Award	Buy	1,778	$4.35	$7.73K	1,778
Jul 03, 2024	Shapiro Aron	director	-	A-Award	Buy	1,778	$4.35	$7.73K	1,778
Jul 03, 2024	Walters-Hoffert Lisa	director	-	A-Award	Buy	1,778	$4.35	$7.73K	1,778
Jul 03, 2024	Hollander David	director	-	A-Award	Buy	1,778	$4.35	$7.73K	1,778
Jul 03, 2024	TYLE PRAVEEN	director	-	A-Award	Buy	1,778	$4.35	$7.73K	1,778
Jun 14, 2024	Tosca Melissa	officer	EVP Finance	P-Purchase	Buy	100	$5.25	$525.00	3,979
Jun 14, 2024	Daniels Eric Joseph	officer	Chief Development Officer	P-Purchase	Buy	1,431	$5.29	$7.57K	11,222
Jun 13, 2024	Parsons Erin	director	-	P-Purchase	Buy	5,260	$4.88	$25.67K	5,260
Jun 13, 2024	Strem Brian M.	director, officer	President and CEO	P-Purchase	Buy	3,000	$5.00	$15.00K	14,531
Oct 03, 2023	Tosca Melissa	officer	EVP Finance	A-Award	Buy	60,000	$0.57	$34.06K	60,000
Oct 03, 2023	Tosca Melissa	officer	EVP Finance	A-Award	Buy	30,000	-	-	34,900

The last insider buy of KPRX was made by Tosca Melissa on Aug 15 2024, buying 2,000 shares at $3.21 per share (worth $6.42K).

Kiora Pharmaceuticals Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q3 2024	13	-	-
Q2 2024	4	-	-
Q3 2023	12	-	-
Q1 2023	12	-	-
Q4 2022	6	-	-
Q3 2022	-	-	-
Q2 2022	-	-	-
Q1 2022	11	3	366.67%
Q4 2021	4	8	50.00%
Q3 2021	2	21	9.52%
Q2 2021	2	12	16.67%
Q1 2021	13	13	100.00%
Q4 2020	-	12	-
Q3 2020	-	12	-
Q2 2020	-	12	-
Q1 2020	17	12	141.67%
Q4 2019	-	14	-
Q3 2019	7	20	35.00%
Q1 2019	17	-	-
Q4 2018	17	-	-

13 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Kiora Pharmaceuticals's insiders, as of Q3 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q3 2024	1	-	-
Q2 2024	4	-	-
Q3 2023	-	-	-
Q1 2023	-	-	-
Q4 2022	-	-	-
Q3 2022	-	-	-
Q2 2022	-	-	-
Q1 2022	-	-	-
Q4 2021	1	-	-
Q3 2021	-	9	-
Q2 2021	-	-	-
Q1 2021	3	-	-
Q4 2020	-	-	-
Q3 2020	-	-	-
Q2 2020	-	-	-
Q1 2020	4	-	-
Q4 2019	-	2	-
Q3 2019	7	15	46.67%
Q1 2019	6	-	-
Q4 2018	17	-	-

As of Q3 2024, Insider owners conducted 1 open market buy trades and 0 open market sell trades of Kiora Pharmaceuticals's stocks.

Kiora Pharmaceuticals Peer Ownership

Ticker	Company
BDRX	Biodexa Pharmaceuticals Plc
BWV	Onconetix, Inc.
PXMD	PaxMedica, Inc. Common Stock
REVB	Revelation Biosciences, Inc.
QNRX	Quoin Pharmaceuticals, Ltd.
HILS	Tharimmune, Inc.
VRAX	Virax Biolabs Group Limited
ALLR	Allarity Therapeutics, Inc.
UNCY	Unicycive Therapeutics, Inc.
CDIO	Cardio Diagnostics Holdings, Inc.
PALI	Palisade Bio, Inc.

KPRX Ownership FAQ

Who Owns Kiora Pharmaceuticals?

Kiora Pharmaceuticals is owned by institutional shareholders (1.12%), insiders (2.31%), and public (96.57%). The largest institutional shareholder of Kiora Pharmaceuticals is ACADIAN ASSET MANAGEMENT LLC (2.93% of total shares) and the top mutual fund owner is FIDELITY COMMONWEALTH TRUST (0.09% of total shares).

Who are the major institutional shareholders of Kiora Pharmaceuticals?

Kiora Pharmaceuticals's major institutional shareholders are ACADIAN ASSET MANAGEMENT LLC, BLACKROCK INC., CITADEL ADVISORS LLC, DIMENSIONAL FUND ADVISORS LP, and VANGUARD GROUP INC. The top five shareholders own together 9.94% of the company's share outstanding.

How many Kiora Pharmaceuticals shareholders are there?

As of Jun 2022, there are 10 institutional shareholders of Kiora Pharmaceuticals.

What percentage of Kiora Pharmaceuticals is owned by ACADIAN ASSET MANAGEMENT LLC?

ACADIAN ASSET MANAGEMENT LLC owns 21.46K shares of Kiora Pharmaceuticals, representing 2.93% of the company's total shares outstanding, valued at $70K (as of Mar 2023).

What percentage of Kiora Pharmaceuticals is owned by BLACKROCK INC?

As of Mar 2023, BLACKROCK INC holds 14.46K shares of Kiora Pharmaceuticals (KPRX), compromising 1.97% of the company, valued at $48.3M.

What percentage of Kiora Pharmaceuticals is owned by CITADEL ADVISORS LLC?

CITADEL ADVISORS LLC is the third largest holder of Kiora Pharmaceuticals. The company owns 14.13K of the company's shares outstanding (worth $47.21M).